METTL3 and neoplasm: In ovarian carcinoma, the depletion of METTL3 in NK cells inhibits cell infiltration ability and functions, leading to accelerated tumor development through a reduction in SHP-2 expression and AKT and MAPK signaling pathway activation (129).